TuHURA BIOSCIENCES, INC./NV Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
TuHURA BIOSCIENCES, INC./NV (HURA) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$3.25 thousand for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-01-18.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperations · last filed 2013-01-18
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2012-12-31 was -$3.25K.
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-12-31 was -$10.92K.
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2011-09-30 was -$3.86K.
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2010-12-31 was -$14.58K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 27 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 30 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 42 month |
|---|---|---|---|---|---|
| 2012-12-31 | -$3.25K 10-Q · filed 2013-01-18 | -$7.41K 10-Q · filed 2013-01-18 | -$65.09K 10-Q · filed 2013-01-18 | ||
| 2011-12-31 | -$10.92K 10-Q · filed 2013-01-18 | -$14.77K 10-Q · filed 2013-01-18 | -$53.58K 10-Q · filed 2012-02-07 | ||
| 2011-09-30 | -$3.86K 10-Q · filed 2011-11-10 | -$42.66K 10-Q · filed 2011-11-10 | |||
| 2010-12-31 | -$14.58K 10-Q · filed 2012-02-07 | -$22.49K 10-Q · filed 2012-02-07 | |||
| 2010-09-30 | -$7.91K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |